These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mechanisms of pulmonary endothelial barrier dysfunction in acute lung injury and acute respiratory distress syndrome. Su Y; Lucas R; Fulton DJR; Verin AD Chin Med J Pulm Crit Care Med; 2024 Jun; 2(2):80-87. PubMed ID: 39006829 [TBL] [Abstract][Full Text] [Related]
3. Cytoskeletal mechanisms regulating vascular endothelial barrier function in response to acute lung injury. Kása A; Csortos C; Verin AD Tissue Barriers; 2015; 3(1-2):e974448. PubMed ID: 25838980 [TBL] [Abstract][Full Text] [Related]
4. Prolyl Hydroxylase Domain-2 Protein Regulates Lipopolysaccharide-Induced Vascular Inflammation. Fan Q; Mao H; Xie L; Pi X Am J Pathol; 2019 Jan; 189(1):200-213. PubMed ID: 30339838 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of purinergic agonist ATPgammaS against acute lung injury. Kolosova IA; Mirzapoiazova T; Moreno-Vinasco L; Sammani S; Garcia JG; Verin AD Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L319-24. PubMed ID: 17993588 [TBL] [Abstract][Full Text] [Related]
6. Agonists for Bitter Taste Receptors T2R10 and T2R38 Attenuate LPS-Induced Permeability of the Pulmonary Endothelium Kertesz Z; Harrington EO; Braza J; Guarino BD; Chichger H Front Physiol; 2022; 13():794370. PubMed ID: 35399266 [TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms in lipopolysaccharide-induced pulmonary endothelial barrier dysfunction. Liu H; Yu X; Yu S; Kou J Int Immunopharmacol; 2015 Dec; 29(2):937-946. PubMed ID: 26462590 [TBL] [Abstract][Full Text] [Related]
8. miR-144-mediated Inhibition of ROCK1 Protects against LPS-induced Lung Endothelial Hyperpermeability. Siddiqui MR; Akhtar S; Shahid M; Tauseef M; McDonough K; Shanley TP Am J Respir Cell Mol Biol; 2019 Aug; 61(2):257-265. PubMed ID: 30811958 [TBL] [Abstract][Full Text] [Related]
9. Extracellular beta-nicotinamide adenine dinucleotide (beta-NAD) promotes the endothelial cell barrier integrity via PKA- and EPAC1/Rac1-dependent actin cytoskeleton rearrangement. Umapathy NS; Zemskov EA; Gonzales J; Gorshkov BA; Sridhar S; Chakraborty T; Lucas R; Verin AD J Cell Physiol; 2010 Apr; 223(1):215-23. PubMed ID: 20054824 [TBL] [Abstract][Full Text] [Related]
17. Dephosphorylation of Y685-VE-Cadherin Involved in Pulmonary Microvascular Endothelial Barrier Injury Induced by Angiotensin II. Wu Z; Wang Z; Dai F; Liu H; Ren W; Chang J; Li B Mediators Inflamm; 2016; 2016():8696481. PubMed ID: 28119542 [TBL] [Abstract][Full Text] [Related]
18. Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection. Birukova AA; Zagranichnaya T; Alekseeva E; Bokoch GM; Birukov KG J Cell Physiol; 2008 Jun; 215(3):715-24. PubMed ID: 18064650 [TBL] [Abstract][Full Text] [Related]
19. Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation. Birukova AA; Zagranichnaya T; Fu P; Alekseeva E; Chen W; Jacobson JR; Birukov KG Exp Cell Res; 2007 Jul; 313(11):2504-20. PubMed ID: 17493609 [TBL] [Abstract][Full Text] [Related]